Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 63

1.

Uncoupling of collagen II metabolism in newly diagnosed, untreated rheumatoid arthritis is linked to inflammation and antibodies against cyclic citrullinated peptides.

Christensen AF, Hørslev-Petersen K, Christgau S, Lindegaard HM, Lottenburger T, Junker K, Hetland ML, Stengaard-Pedersen K, Jacobsen S, Ellingsen T, Andersen LS, Hansen I, Skjødt H, Pedersen JK, Lauridsen UB, Svendsen AJ, Tarp U, Pødenphant J, Heegaard NH, Vestergaard A, Jurik AG, Ostergaard M, Junker P.

J Rheumatol. 2010 Jun;37(6):1113-20. doi: 10.3899/jrheum.091265. Epub 2010 May 1.

PMID:
20436079
2.

Structures of strontium diformate and strontium fumarate. A synchrotron powder diffraction study.

Ståhl K, Andersen JE, Shim I, Christgau S.

Acta Crystallogr B. 2009 Aug;65(Pt 4):481-7. doi: 10.1107/S0108768109023489. Epub 2009 Jul 16.

PMID:
19617684
3.

Differential association of the N-propeptide of collagen IIA (PIIANP) and collagen II C-telopeptide (CTX-II) with synovitis and erosions in early and longstanding rheumatoid arthritis.

Christensen AF, Lottenburger T, Lindegaard H, Christgau S, Hørslev-Petersen K, Junker P.

Clin Exp Rheumatol. 2009 Mar-Apr;27(2):307-14.

PMID:
19473573
4.

Posttranslational Protein Modifications in Type 1 Diabetes - Genetic Studies with PCMT1, the Repair Enzyme Protein Isoaspartate Methyltransferase (PIMT) Encoding Gene.

Wägner AM, Cloos P, Bergholdt R, Eising S, Brorsson C, Stalhut M, Christgau S, Nerup J, Pociot F.

Rev Diabet Stud. 2008 Winter;5(4):225-31. doi: 10.1900/RDS.2008.5.225. Epub 2009 Feb 10.

5.
6.

Urinary markers of altered collagen metabolism in fibromyalgia patients.

Ribel-Madsen S, Christgau S, Gronemann ST, Bartels EM, Danneskiold-Samsøe B, Bliddal H.

Scand J Rheumatol. 2007 Nov-Dec;36(6):470-7.

PMID:
18092271
7.

Biomarkers predict radiographic progression in early rheumatoid arthritis and perform well compared with traditional markers.

Young-Min S, Cawston T, Marshall N, Coady D, Christgau S, Saxne T, Robins S, Griffiths I.

Arthritis Rheum. 2007 Oct;56(10):3236-47.

8.

Post-translational protein modifications in type 1 diabetes: a role for the repair enzyme protein-L-isoaspartate (D-aspartate) O-methyltransferase?

Wägner AM, Cloos P, Bergholdt R, Boissy P, Andersen TL, Henriksen DB, Christiansen C, Christgau S, Pociot F, Nerup J.

Diabetologia. 2007 Mar;50(3):676-81. Epub 2007 Jan 10.

PMID:
17216280
9.

Strontium diibuprofenate dihydrate, strontium malonate sesquihydrate, strontium diascorbate dihydrate and strontium 2-oxidobenzoate hydrate at 120 K.

Stahl K, Andersen JE, Christgau S.

Acta Crystallogr C. 2006 Apr;62(Pt 4):m144-9. Epub 2006 Mar 18. No abstract available.

PMID:
16598123
10.

Sex hormones in the regulation of bone and cartilage metabolism: an old paradigm and a new challenge.

Christgau S, Cloos PA.

Minerva Ginecol. 2005 Dec;57(6):611-7. Review.

PMID:
16306865
11.

Strontium D-glutamate hexahydrate and strontium di(hydrogen L-glutamate) pentahydrate.

Christgau S, Odderhede J, Stahl K, Andersen JE.

Acta Crystallogr C. 2005 Jun;61(Pt 6):m259-62. Epub 2005 May 13.

PMID:
15930658
12.

New serum biochemical markers (Coll 2-1 and Coll 2-1 NO2) for studying oxidative-related type II collagen network degradation in patients with osteoarthritis and rheumatoid arthritis.

Deberg M, Labasse A, Christgau S, Cloos P, Bang Henriksen D, Chapelle JP, Zegels B, Reginster JY, Henrotin Y.

Osteoarthritis Cartilage. 2005 Mar;13(3):258-65.

13.
14.

Characterization of aged osteocalcin fragments derived from bone resorption.

Cloos PA, Christgau S.

Clin Lab. 2004;50(9-10):585-98.

PMID:
15481635
15.
16.

Suppression of elevated cartilage turnover in postmenopausal women and in ovariectomized rats by estrogen and a selective estrogen-receptor modulator (SERM).

Christgau S, Tankó LB, Cloos PA, Mouritzen U, Christiansen C, Delaissé JM, Høegh-Andersen P.

Menopause. 2004 Sep-Oct;11(5):508-18.

PMID:
15356403
17.

A new marker for osteoarthritis: cross-sectional and longitudinal approach.

Reijman M, Hazes JM, Bierma-Zeinstra SM, Koes BW, Christgau S, Christiansen C, Uitterlinden AG, Pols HA.

Arthritis Rheum. 2004 Aug;50(8):2471-8.

18.

Type II collagen peptides for measuring cartilage degradation.

Henrotin Y, Deberg M, Dubuc JE, Quettier E, Christgau S, Reginster JY.

Biorheology. 2004;41(3-4):543-7.

PMID:
15299285
19.

An immunoassay for measuring fragments of newly synthesized collagen type I produced during metastatic invasion of bone.

Cloos PA, Lyubimova N, Solberg H, Qvist P, Christiansen C, Byrjalsen I, Christgau S.

Clin Lab. 2004;50(5-6):279-89.

PMID:
15209436
20.
21.

Cartilage destruction in collagen induced arthritis assessed with a new biochemical marker for collagen type II C-telopeptide fragments.

Ishikawa T, Nishigaki F, Christgau S, Noto T, Mo J, From N, Minoura K, Hirayama Y, Ohkubo Y, Mutoh S.

J Rheumatol. 2004 Jun;31(6):1174-9.

PMID:
15170932
22.

Ovariectomized rats as a model of postmenopausal osteoarthritis: validation and application.

Høegh-Andersen P, Tankó LB, Andersen TL, Lundberg CV, Mo JA, Heegaard AM, Delaissé JM, Christgau S.

Arthritis Res Ther. 2004;6(2):R169-80. Epub 2004 Feb 19.

23.

Osteoarthritic patients with high cartilage turnover show increased responsiveness to the cartilage protecting effects of glucosamine sulphate.

Christgau S, Henrotin Y, Tankó LB, Rovati LC, Collette J, Bruyere O, Deroisy R, Reginster JY.

Clin Exp Rheumatol. 2004 Jan-Feb;22(1):36-42.

PMID:
15005002
24.

Increased urinary concentration of collagen type II C-telopeptide fragments in patients with osteoarthritis.

Jung M, Christgau S, Lukoschek M, Henriksen D, Richter W.

Pathobiology. 2004;71(2):70-6.

PMID:
14707441
25.

Current and future applications of bone turnover markers.

Christgau S, Cloos PA.

Clin Lab. 2003;49(9-10):439-46. Review. No abstract available.

PMID:
14572198
26.

Endothelin 1 promotes osteoarthritic cartilage degradation via matrix metalloprotease 1 and matrix metalloprotease 13 induction.

Roy-Beaudry M, Martel-Pelletier J, Pelletier JP, M'Barek KN, Christgau S, Shipkolye F, Moldovan F.

Arthritis Rheum. 2003 Oct;48(10):2855-64.

27.

Urinary type II collagen C-telopeptide levels are increased in patients with rapidly destructive hip osteoarthritis.

Garnero P, Conrozier T, Christgau S, Mathieu P, Delmas PD, Vignon E.

Ann Rheum Dis. 2003 Oct;62(10):939-43.

28.

Dose dependent effects on bone resorption and formation of intermittently administered intravenous ibandronate.

Christiansen C, Tankó LB, Warming L, Moelgaard A, Christgau S, Qvist P, Baumann M, Wieczorek L, Hoyle N.

Osteoporos Int. 2003 Jul;14(7):609-13. Epub 2003 Jun 26.

PMID:
12830369
29.

Breast cancer patients with bone metastases are characterised by increased levels of nonisomerised type I collagen fragments.

Cloos PA, Christgau S, Lyubimova N, Body JJ, Qvist P, Christiansen C.

Breast Cancer Res. 2003;5(4):R103-9. Epub 2003 May 19.

30.

Oral ibandronate: changes in markers of bone turnover during adequately dosed continuous and weekly therapy and during different suboptimally dosed treatment regimens.

Tankó LB, Mouritzen U, Lehmann HJ, Warming L, Moelgaard A, Christgau S, Qvist P, Baumann M, Wieczorek L, Hoyle N, Christiansen C.

Bone. 2003 Jun;32(6):687-93.

PMID:
12810176
32.

Association of baseline levels of markers of bone and cartilage degradation with long-term progression of joint damage in patients with early rheumatoid arthritis: the COBRA study.

Garnero P, Landewé R, Boers M, Verhoeven A, Van Der Linden S, Christgau S, Van Der Heijde D, Boonen A, Geusens P.

Arthritis Rheum. 2002 Nov;46(11):2847-56.

33.

Uncoupling of type II collagen synthesis and degradation predicts progression of joint damage in patients with knee osteoarthritis.

Garnero P, Ayral X, Rousseau JC, Christgau S, Sandell LJ, Dougados M, Delmas PD.

Arthritis Rheum. 2002 Oct;46(10):2613-24.

34.

Investigation of bone disease using isomerized and racemized fragments of type I collagen.

Cloos PA, Fledelius C, Christgau S, Christiansen C, Engsig M, Delmas P, Body JJ, Garnero P.

Calcif Tissue Int. 2003 Jan;72(1):8-17. Epub 2002 Oct 21.

PMID:
12384813
36.

Effect of bisphosphonates on cartilage turnover assessed with a newly developed assay for collagen type II degradation products.

Lehmann HJ, Mouritzen U, Christgau S, Cloos PA, Christiansen C.

Ann Rheum Dis. 2002 Jun;61(6):530-3.

37.
39.

Mechanism of circadian variation in bone resorption.

Bjarnason NH, Henriksen EE, Alexandersen P, Christgau S, Henriksen DB, Christiansen C.

Bone. 2002 Jan;30(1):307-13.

PMID:
11792602
40.

Bone resorption in post-menopausal women with normal and low BMD assessed with biochemical markers specific for telopeptide derived degradation products of collagen type I.

Reginster JY, Henrotin Y, Christiansen C, Gamwell-Henriksen E, Bruyere, Collette J, Christgau S.

Calcif Tissue Int. 2001 Sep;69(3):130-7.

41.

Collagen type II C-telopeptide fragments as an index of cartilage degradation.

Christgau S, Garnero P, Fledelius C, Moniz C, Ensig M, Gineyts E, Rosenquist C, Qvist P.

Bone. 2001 Sep;29(3):209-15.

PMID:
11557363
43.
44.

Serum CrossLaps for monitoring the response in individuals undergoing antiresorptive therapy.

Christgau S, Bitsch-Jensen O, Hanover Bjarnason N, Gamwell Henriksen E, Qvist P, Alexandersen P, Bang Henriksen D.

Bone. 2000 May;26(5):505-11.

PMID:
10773591
45.

Circadian variation in serum CrossLaps concentration is reduced in fasting individuals.

Christgau S.

Clin Chem. 2000 Mar;46(3):431. No abstract available.

46.

Crystallization and preliminary X-ray studies of beta-1, 4-galactanase from Aspergillus aculeatus.

Ryttersgaard C, Poulsen J, Christgau S, Sandal T, Dalbøge H, Larsen S.

Acta Crystallogr D Biol Crystallogr. 1999 Apr;55(Pt 4):929-30.

PMID:
10089338
47.

Clinical evaluation of the Serum CrossLaps One Step ELISA, a new assay measuring the serum concentration of bone-derived degradation products of type I collagen C-telopeptides.

Christgau S, Rosenquist C, Alexandersen P, Bjarnason NH, Ravn P, Fledelius C, Herling C, Qvist P, Christiansen C.

Clin Chem. 1998 Nov;44(11):2290-300.

48.
49.

Crystallization and preliminary X-ray studies of rhamnogalacturonase A from Aspergillus aculeatus.

Petersen TN, Christgau S, Kofod LV, Kauppinen S, Johnson AH, Larsen S.

Acta Crystallogr D Biol Crystallogr. 1997 Jan 1;53(Pt 1):105-7.

PMID:
15299976
50.

Pectin methyl esterase from Aspergillus aculeatus: expression cloning in yeast and characterization of the recombinant enzyme.

Christgau S, Kofod LV, Halkier T, Andersen LN, Hockauf M, Dörreich K, Dalbøge H, Kauppinen S.

Biochem J. 1996 Nov 1;319 ( Pt 3):705-12.

Supplemental Content

Loading ...
Support Center